ITGAX and neoplasm: This suggests that whilst IL-2/CD40 reduces tumor-induced suppressive TDLN CD11c+ cells, it does not overcome the age-related increase in suppressive CD11c+ cells, which may be a contributing factor to the reduced efficacy of IL-2/CD40 in elderly mice.